Ongeveer 114.000 resultaten
Koppelingen in nieuw tabblad openen
  1. VALTOCO® (diazepam nasal spray) Frequently Asked Questions

    VALTOCO® (diazepam nasal spray) is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizures) that are distinct …

  2. NEURELIS ANNOUNCES FDA APPROVAL FOR IMMEDIATE USE SEIZURE

    16 apr. 2025 · Indication VALTOCO® (diazepam nasal spray) is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive …

  3. VALTOCO ® (Diazepam Nasal Spray) for the Acute Treatment of ...

    Valtoco® is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age …

  4. Clinical Guideline Benzodiazepines for Acute Repetitive Seizures or ...

    Diazepam rectal gel - for acute repetitive seizure treatment in patients with epilepsy ages 2 years and older. Valtoco (diazepam nasal spray) - for acute repetitive seizure treatment in patients with epilepsy …

  5. Valtoco Nasal Spray for Seizure Clusters - WebMD

    17 jul. 2024 · Valtoco (diazepam nasal spray) is a prescription medicine for quick and effective treatment of seizure clusters, also known as acute repetitive seizures, in people with epilepsy.

  6. NEURELIS ANNOUNCES FDA APPROVAL FOR IMMEDIATE USE SEIZURE

    16 apr. 2025 · VALTOCO maintains orphan drug exclusivity for VALTOCO to treat episodes of frequent seizures SAN DIEGO, April 16, 2025 /PRNewswire/ -- Neurelis, Inc., today announced that the U.S. Food …

  7. Frequently Asked Questions about VALTOCO - valtocohcp.com

    VALTOCO® (diazepam nasal spray) is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizures) that are distinct …

  8. FDA approval for Valtoco (diazepam nasal spray) for short-term ...

    25 apr. 2025 · Neurelis, Inc., announced that the FDA has approved Valtoco (diazepam nasal spray) for short-term treatment of seizure clusters (also known as “acute repetitive seizures”) that are different …

  9. FDA Expands Diazepam Nasal Spray Indication to Treat Ages 2 to 5

    16 apr. 2025 · The FDA has approved an expanded indication for diazepam nasal spray (Valtoco; Neurelis), now allowing its use in children ages 2 to 5 for the treatment of seizure clusters, also known …

  10. HIGHLIGHTS OF PRESCRIBING INFORMATION - Epilepsy Foundation

    VALTOCO is a benzodiazepine indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a …